A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
Clinical trial NCT04285229 · COMPLETED
Trial details
- NCT number
- NCT04285229
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2021-03-31
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.